Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Latest Information Update: 23 Jul 2024
At a glance
- Drugs Abatacept (Primary) ; Ciclosporin; Methotrexate; Tacrolimus
- Indications Graft-versus-host disease; Transplant rejection
- Focus Registrational; Therapeutic Use
- Acronyms ABA2; GVHD-1
- 17 Jul 2024 Status changed from active, no longer recruiting to completed.
- 15 Jun 2023 Results of abatacept pharmacokinetics , examining abatacept exposure-response (E-R) relationships impact on key clinical outcomes, published in the Blood
- 25 Apr 2023 Planned End Date changed from 1 Feb 2023 to 1 Sep 2023.